盎塞 ASGN 深 滬
已收盤 07-18 16:00:00 美东时间
48.41
-1.110
-2.24%
華盛通- 最 高49.82
- 今 開49.82
- 成交量 45.73万股
- 最 低 48.05
- 昨 收 49.52
- 總市值 21.20亿
- 52周最高 101.66
- 市盈率 靜 12.63
- 換手率 1.04%
- 52周最低 46.635
- 委 比 84.00%
- 總股本 4380.00万
- 歷史最高 131.89
- 量 比 0.89
- 振 幅 3.57%
- 歷史最低 6.27
- 每 手 1
- 風險率 5.34%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅199.47%！杰富瑞上调Cogent Biosciences目标价至28美元，维持"买入"评级
今日重点评级关注：杰富瑞：维持Cogent Biosciences"买入"评级，目标价从23美元升至28美元；Leerink Partners：维持Cogent Biosciences"跑赢大市"评级，目标价从16美元升至18美元
07-08 09:34
Beyond The Numbers: 5 Analysts Discuss ASGN Stock
ASGN (NYSE:ASGN) underwent analysis by 5 analysts in the last quarter, revealin...
07-07 21:02
Jefferies Downgrades ASGN to Underperform, Lowers Price Target to $42
Jefferies analyst Surinder Thind downgrades ASGN (NYSE:ASGN) from Hold to Underperform and lowers the price target from $53 to $42.
07-07 20:06
Jefferies downgrades ASGN (ASGN) to a Sell
ASGN received a Sell rating and a $42.00 price target from Jefferies analyst Su...
07-07 17:16
SmartBug Media® Promotes Adam Bleibtreu to CEO
Founder Ryan Malone Returns to Board Chairman, Passes the Baton to Bleibtreu in Strategic Leadership Transition IRVINE, Calif., June 4, 2025 /PRNewswire/ -- SmartBug Media® — HubSpot's most ...
06-05 01:01
美股大行评级 | 潜在涨幅417.8%！RBC Capital上调Perspective Therapeutics目标价至16美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1136940401951563776.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• RBC Capital：维持Perspective Therapeutics(CATX)"跑赢大市"评级，目标价从15美元升至16美元</p> <p>• Canaccord Genuity：维持Taysha Gene Th
06-04 08:35
Demystifying ASGN: Insights From 4 Analyst Reviews
4 analysts have expressed a variety of opinions on ASGN (NYSE:ASGN) over the pa...
06-03 21:00
Wells Fargo Initiates Coverage On ASGN with Equal-Weight Rating, Announces Price Target of $56
Wells Fargo analyst Jason Haas initiates coverage on ASGN (NYSE:ASGN) with a Equal-Weight rating and announces Price Target of $56.
06-03 20:43
Looking Into ASGN's Recent Short Interest
ASGN's (NYSE:ASGN) short percent of float has risen 25.36% since its last repor...
05-21 03:00
ASGN sees $985M–$1.015B Q2 revenue amid TopBloc integration and AI growth focus
Earnings Call Insights: ASGN Incorporated (ASGN) Q1 2025 Management View CEO Ted Hanson highlighted that Q1 revenues of $968.3 million and an adjusted EBITDA margin of 9.7% aligned with guidance expec...
04-24 07:27
